Thus, our results uncovered a novel mechanism of HCC growth regulation by activating the NCOA3/SP1/hTERT axis, and indicating that the NCOA3-Sp1-TERT axis could be a potential therapeutic target for HCC. The gene discussed is SP1; the disease is hepatocellular carcinoma.